As the COVID-19 pandemic unfolded, scientists began researching outpatient treatment options to combat the virus in its early stages. The goal of these studies is to reduce hospitalizations and improve patient outcomes.

One of the options showing tremendous promise for treating COVID-19 early in its course is monoclonal antibodies. On Nov. 21, monoclonal antibodies received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). Shortly after, on Dec. 1, Maury Regional Health (MRH) opened a monoclonal antibody intravenous clinic on the campus of Maury Regional Me...